Capiibine 500 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Capiibine 500 mg Tablet contains capecitabine, an oral fluoropyrimidine chemotherapy medicine. Its labelling describes it for the treatment of breast cancer, colon cancer, and rectal cancer, and other conditions as the doctor recommends. It is prescribed alone or combined with other chemotherapy drugs. A healthcare expert decides the dosage and how and when to take it, which varies with what is being treated.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Breast cancer — metastatic breast cancer where other treatments have failed, alone or with docetaxel
- Colorectal cancer — colon and rectal cancer, alone or with oxaliplatin
- Stomach cancer — combined with other drugs
Described Dosage & Administration
- An oral medicine taken as per the doctor’s prescription
- The dosage varies depending on body size, symptoms, kidney function, cancer type, and lab test results
- A dose should not be skipped or exceeded, as this may lead to serious side effects; results may take several weeks or months and the medicine should not be stopped abruptly
Described Side Effects
Commonly described side effects include:
- Vomiting
- Weakness
- Nausea
- Loss of appetite
- Abdominal pain
- Diarrhoea
These are described as commonly temporary; the doctor should be informed if symptoms persist for long. The medicine can also reduce the white blood cell count.
Precautions
- Regular blood tests, along with heart and liver monitoring and uric acid level checks, are recommended
- The doctor should be informed of any liver or kidney problems
- Pregnant women or breastfeeding mothers should consult their doctor before starting; both men and women must use contraception during treatment
- Alcohol should be avoided
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains capecitabine and is used for the treatment of breast cancer, colorectal cancer, and stomach cancer. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as an oral tablet taken as per the doctor’s prescription, with the dosage varying by body size, kidney function, cancer type, and lab results; it should not be skipped, exceeded, or stopped abruptly.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.